>
感染症研究に使用するコア試薬
![]() MPXV | ![]() Coronavirus | ![]() Influenza | ![]() RABV | ![]() EBOV | ![]() HIV |
![]() VZV | ![]() ZIKV | ![]() RSV | ![]() NiV | ![]() SFTSV |
>>> SARS-CoV-2関連製品:COVID-19ワクチン開発&研究用の抗原 , 診断キット開発用の抗原と抗体 , SARS-CoV-2検出キット, 偽ウイルス中和アッセイサービス
>>> フォーカス製品: Hemagglutinin (HA), Neuraminidase (NA)
>>> フォーカス製品: Glycoprotein, Anti-RABV glycoprotein antibody
>>> フォーカス製品: Glycoprotein
>>> フォーカス製品: gp41, gp120, Capsid protein p24, HLA-A*0201 | B2M & HIV Gag (SLYNTVATL)
>>> フォーカス製品: Glycoprotein E
>>> フォーカス製品: NS1
>>> フォーカス製品: Glycoprotein G, Fusion glycoprotein F0 (Pre-fusion, Post-fusion)
>>> フォーカス製品: Glycoprotein, Fusion glycoprotein
>>> フォーカス製品: Gn protein
HEK293による発現:タンパク質の構造は自然なコンフォメーションに近いです;
DS-PAGEとMALSによって検証された高純度;
抗原抗体または抗原受容体結合試験によって検証された高い生物活性;
高い免疫原性:より高い抗体力価を誘発できます;
薬物スクリーニングやワクチン開発に適しています。
RSV
influenza
VZV
MPXV
HIV
RABV
HSV
NiV
HeV
ZIKV
DENV
SFTSV
EBV
EBOV
Rotavirus
Coxsackievirus
LCMV
Vaccinia Virus
HCMV
hMPV
JEV
HPV
MuV
RV
HTNV
TBEV
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
product type | molecule | Cat. No. | Product Description |
---|
The purity of HRSV (A) Fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H6) is more than 95% verified by SDS-PAGE and 90% and verified by SEC-MALS. The molecular weight of this protein is around 148-182kDa.
Immobilized HRSV (A) Fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H7) at 2 μg/mL (100 μL/well) can bind Anti-Fusion glycoprotein F0 Antibody, Human IgG1 (D25) with a linear range of 0.2-1 ng/mL (QC tested).
Immobilized HRSV (A) Fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H7) at 2 μg/mL (100 μL/well) can bind Anti-Fusion glycoprotein F0 Antibody, Mouse IgG2a (101F) with a linear range of 0.2-5 ng/mL (Routinely tested).
Loaded Monoclonal Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (Cat. No. SPD-M305) on AMC Biosensor, can bind SARS-CoV-2 Spike RBD, His Tag (B.1.1.529/Omicron) (Cat. No. SPD-C522e) with an affinity constant of 9.07 nM as determined in BLI assay (ForteBio Octet Red96e).
Post-vaccination serum samples are tested with Anti-SARS-CoV-2 Antibody IgG Titer Serologic Assay Kit (Spike RBD) (Cat. No.RAS-T024), which accurately and precisely measure antibody titer in serum (Accuracy≤±15%; Intra-assay precision<10%; Inter-assay precision <15%).
SARS-CoV-2 Spike (WT) Fluc-GFP Pseudovirus (Cat. No. PSSW-HLGB001) and SARS-CoV-2 Spike (Omicron) Fluc-GFP Pseudovirus (Cat. No. PSSO-HLGB003) can be neutralized by Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody (Cat. No. SPD-M265, S1N-M122) with inhibition rates of more than 99%. The antibody, REGN10987, which has been reported that Omicron mutant strain can escape, can effectively neutralize SARS-CoV-2 Spike (WT) Fluc-GFP Pseudovirus (Cat. No. PSSW-HLGB001) but not SARS-CoV-2 Spike (Omicron) Fluc-GFP Pseudovirus (Cat. No. PSSO-HLGB003).
SARS-CoV-2 Spike (Omicron) Fluc-GFP Pseudovirus (Cat. No. PSSO-HLGB003) can be neutralized by serum from immunized mice. The inhibition rates come up to more than 99%.
This web search service is supported by Google Inc.